Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)

NCT04415047 is registered in ClinicalTrials.gov with JenaValve Technology, Inc. as lead sponsor.

NCT NCT04415047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04415047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
Lead sponsor
JenaValve Technology, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 22, 2020
Completion date
August 31, 2028
Enrollment
180 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

aortic insufficiency, aortic regurgitation, aortic valve disease, aortic valve insufficiency